Common Stock, Shares Authorized of Freeline Therapeutics Holdings plc from 31 Dec 2019 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Freeline Therapeutics Holdings plc quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2019 to 30 Sep 2023.
  • Freeline Therapeutics Holdings plc Common Stock, Shares Authorized for the quarter ending 30 Sep 2023 was 400,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Freeline Therapeutics Holdings plc Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 400,000,000 0 0% 30 Sep 2023 6-K 01 Dec 2023 2023 Q3
Q2 2023 400,000,000 0 0% 30 Jun 2023 6-K 15 Aug 2023 2023 Q2
Q1 2023 400,000,000 +240,000,000 +150% 31 Mar 2023 6-K 30 May 2023 2023 Q1
Q4 2022 400,000,000 +240,000,000 +150% 31 Dec 2022 6-K 01 Dec 2023 2023 Q3
Q3 2022 400,000,000 +240,000,000 +150% 30 Sep 2022 6-K 15 Nov 2022 2022 Q3
Q2 2022 400,000,000 +240,000,000 +150% 30 Jun 2022 6-K 09 Aug 2022 2022 Q2
Q1 2022 160,000,000 0 0% 31 Mar 2022 6-K 10 May 2022 2022 Q1
Q4 2021 160,000,000 0 0% 31 Dec 2021 20-F 04 Apr 2023 2022 FY
Q3 2021 160,000,000 30 Sep 2021 6-K 09 Nov 2021 2021 Q3
Q2 2021 160,000,000 -540,000,000 -77% 30 Jun 2021 6-K 16 Aug 2021 2021 Q2
Q1 2021 160,000,000 31 Mar 2021 6-K 17 May 2021 2021 Q1
Q4 2020 160,000,000 -540,000,000 -77% 31 Dec 2020 20-F 31 Mar 2022 2021 FY
Q2 2020 700,000,000 30 Jun 2020 6-K 29 Oct 2020
Q4 2019 700,000,000 31 Dec 2019 6-K 29 Oct 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.